Does MEROPENEM ANHYDROUS Cause Hepatic cytolysis? 13 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 13 reports of Hepatic cytolysis have been filed in association with MEROPENEM ANHYDROUS (Meropenem). This represents 9.0% of all adverse event reports for MEROPENEM ANHYDROUS.
13
Reports of Hepatic cytolysis with MEROPENEM ANHYDROUS
9.0%
of all MEROPENEM ANHYDROUS reports
0
Deaths
12
Hospitalizations
How Dangerous Is Hepatic cytolysis From MEROPENEM ANHYDROUS?
Of the 13 reports, 12 (92.3%) required hospitalization.
Is Hepatic cytolysis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for MEROPENEM ANHYDROUS. However, 13 reports have been filed with the FAERS database.
What Other Side Effects Does MEROPENEM ANHYDROUS Cause?
Drug reaction with eosinophilia and systemic symptoms (31)
Agranulocytosis (17)
Cholestasis (16)
Toxic epidermal necrolysis (12)
Encephalopathy (8)
Eosinophilia (8)
Neutropenia (7)
Quadriparesis (6)
Rash maculo-papular (6)
Rash morbilliform (6)
What Other Drugs Cause Hepatic cytolysis?
ACETAMINOPHEN (1,469)
ATORVASTATIN (681)
PEMBROLIZUMAB (601)
CARBOPLATIN (577)
METHOTREXATE (468)
SULFAMETHOXAZOLE\TRIMETHOPRIM (356)
PACLITAXEL (324)
ENOXAPARIN (307)
AMOXICILLIN (273)
VALACYCLOVIR (261)
Which MEROPENEM ANHYDROUS Alternatives Have Lower Hepatic cytolysis Risk?
MEROPENEM ANHYDROUS vs MESALAMINE
MEROPENEM ANHYDROUS vs MESNA
MEROPENEM ANHYDROUS vs METAMIZOLE
MEROPENEM ANHYDROUS vs METARAMINOL
MEROPENEM ANHYDROUS vs METAXALONE